Size at birth and plasma insulin-like growth factor-1 concentrations.

OBJECTIVE--To test the hypothesis that reduced fetal growth leads to altered plasma insulin-like growth factor-1 (IGF-1) concentrations in childhood. DESIGN--A follow up study of 4 year old children whose birth weights were recorded, and of 7 year old children whose weight, length, head circumference, and placental weight were measured at birth. SETTING--Pune, India, and Salisbury, England. SUBJECTS--200 children born during October 1987 to April 1989 in the King Edward Memorial Hospital, Pune, weighing over 2.0 kg at birth and not requiring special care, and 244 children born during July 1984 to February 1985 in the Salisbury Health District and still living there. MAIN OUTCOME MEASURE--Plasma IGF-1 concentrations. RESULTS--In both groups of children, and consistent with findings in other studies, plasma IGF-1 concentrations were higher in taller and heavier children, and higher in girls than boys. Allowing for sex and current size, concentrations were inversely related to birth weight (Pune p = 0.002; Salisbury p = 0.003). Thus at any level of weight or height, children of lower birth weight had higher IGF-1 concentrations. The highest concentrations were in children who were below average birth weight and above average weight or height when studied. Systolic blood pressures were higher in children with higher IGF-1 concentrations (Pune p = 0.01; Salisbury p = 0.04). CONCLUSIONS--Children of lower birth weight develop higher circulating concentrations of IGF-1 than expected for their height and weight. This is consistent with the hypothesis that under-nutrition in utero leads to reprogramming of the IGF-1 axis. The increase of plasma IGF-1 concentrations in low birthweight children may also be linked to postnatal catch-up growth. High IGF-1 concentrations may be one of the mechanisms linking reduced fetal growth and high blood pressure in later life.

[1]  G. Putet,et al.  Functional hypersomatotropism in small for gestational age (SGA) newborn infants. , 1989, The Journal of clinical endocrinology and metabolism.

[2]  F. Daffos,et al.  Serum somatomedin-C and bioassayable growth-promoting activity (thymidine activity) in appropriate and small-for-gestational-age human newborns. , 1985, Acta endocrinologica.

[3]  C Osmond,et al.  Fetal and infant growth and impaired glucose tolerance at age 64. , 1991, BMJ.

[4]  I. K. Ashton,et al.  Somatomedin activity in human cord plasma and relationship to birth size, insulin, growth hormone, and prolactin. , 1978, Early human development.

[5]  J. Verhaeghe,et al.  C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. , 1993, American journal of obstetrics and gynecology.

[6]  I. Morita,et al.  Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cells. , 1992, Atherosclerosis.

[7]  C. Osmond,et al.  Maternal and fetal influences on blood pressure. , 1991, Archives of disease in childhood.

[8]  C Osmond,et al.  The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. , 1993, BMJ.

[9]  H. C. Miller,et al.  Postnatal somatic growth in infants with atypical fetal growth patterns. , 1977, American journal of diseases of children.

[10]  D. Clemmons,et al.  Nutritional regulation of IGF-I and IGF binding proteins. , 1991, Annual review of nutrition.

[11]  N. Skakkebaek,et al.  Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. , 1994, The Journal of clinical endocrinology and metabolism.

[12]  D. Clemmons,et al.  Failure of insulin-like growth factor-I (IGF-I) infusion to promote growth in protein-restricted rats despite normalization of serum IGF-I concentrations. , 1991, Endocrinology.

[13]  T. Meade,et al.  Fetal and infant growth and cardiovascular risk factors in women , 1995, BMJ.

[14]  P. Gluckman,et al.  Insulin-like growth factors and their binding proteins in plasma and milk after growth hormone-stimulated galactopoiesis in normally lactating women. , 1993, Acta endocrinologica.

[15]  M. Ranke,et al.  Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. , 1993, The Journal of clinical endocrinology and metabolism.

[16]  D. Cook,et al.  Early influences on blood pressure: a study of children aged 5-7 years. , 1989, BMJ.

[17]  A. Leung,et al.  Serum immunoreactive somatomedin levels in normal adults, pregnant women at term, children at various ages, and children with constitutionally delayed growth. , 1981, The Journal of clinical endocrinology and metabolism.

[18]  C Osmond,et al.  Early growth and death from cardiovascular disease in women. , 1993, BMJ.

[19]  J. Dobbing,et al.  Fetal nutrition and cardiovascular disease in adult life , 1993, The Lancet.

[20]  D. Bhat,et al.  Fetal Growth and Glucose and Insulin Metabolism in Four‐year‐old Indian Children , 1995, Diabetic medicine : a journal of the British Diabetic Association.

[21]  L. Tatò,et al.  A longitudinal study on plasma somatomedin activity in full-term, preterm and small-for-gestational age newborns. , 1981, Biology of the neonate.

[22]  C Osmond,et al.  Initiation of hypertension in utero and its amplification throughout life. , 1993, BMJ.

[23]  T. Chard,et al.  The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: relation to fetal weight. , 1991, The Journal of endocrinology.

[24]  D. Bowsher,et al.  A Prospective Study of Painful Symptoms, Small‐fibre Function and Peripheral Vascular Disease in Chronic Painful Diabetic Neuropathy , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[25]  J. Pearson,et al.  Revised Gairdner-Pearson growth charts , 1985 .

[26]  J. Boccara,et al.  Serum Insulin-Like Growth Factor 1 and Serum Growth-Promoting Activity during the First Postnatal Year in Infants with Intrauterine Growth Retardation , 1988, Pediatric Research.

[27]  M. Rechler,et al.  Expression of the genes for insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding proteins-1 and -2 in fetal rat under conditions of intrauterine growth retardation caused by maternal fasting. , 1991, Endocrinology.

[28]  P. Gluckman,et al.  Fetal Growth: an Endocrine Perspective , 1989, Acta paediatrica Scandinavica. Supplement.

[29]  D. Barker,et al.  Fetal influences on blood pressure. , 1994, Journal of hypertension.

[30]  Darrell M. Wilson,et al.  Levels of insulin-like growth factors I and II in human cord blood. , 1983, The Journal of clinical endocrinology and metabolism.

[31]  J. Wigglesworth Lesions in the neonatal brain. , 1985, Archives of disease in childhood.

[32]  D. Barker Mothers, Babies and Disease in Later Life , 1994 .

[33]  C. Kahn,et al.  Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. , 1985, The Journal of clinical investigation.

[34]  K. Nicolaides,et al.  The pathophysiology of the insulin‐like growth factor axis in fetal growth failure: a basis for programming by undernutrition? , 1994, European journal of clinical investigation.

[35]  D. Barker,et al.  Thinness at Birth and Glucose Tolerance in Seven‐year‐old Children , 1995, Diabetic medicine : a journal of the British Diabetic Association.

[36]  J. Miell,et al.  The insulin‐like growth factor‐I/binding protein axis: physiology, pathophysiology and therapeutic manipulation , 1993, European journal of clinical investigation.

[37]  I. Mackenzie,et al.  Insulin-like growth factors (IGF) 1 and 2 in human foetal plasma and relationship to gestational age and foetal size during midpregnancy. , 1985, Acta endocrinologica.

[38]  R. Martorell,et al.  Heterogeneous growth and mental development of intrauterine growth-retarded infants during the first 3 years of life. , 1984, Pediatrics.

[39]  T. Foley,et al.  Low somatomedin activity in cord serum from infants with intrauterine growth retardation. , 1980, The Journal of pediatrics.

[40]  D. Straus Nutritional regulation of hormones and growth factors that control mammalian growth , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  P. Gluckman,et al.  Somatomedin in cord blood: relationship to gestational age and birth size. , 1976, The Journal of clinical endocrinology and metabolism.

[42]  S. Harrap,et al.  Essential hypertension: a disorder of growth with origins in childhood? , 1992, Journal of hypertension.

[43]  Clive Osmond,et al.  Fetal and placental size and risk of hypertension in adult life. , 1990, BMJ.

[44]  M. Binoux,et al.  Serum Insulin-Like Growth Factors and Insulin-Like Growth Factor Binding Proteins in the Human Fetus. Relationships with Growth in Normal Subjects and in Subjects with Intrauterine Growth Retardation , 1991, Pediatric Research.

[45]  P C Evans,et al.  Glucose but Not a Mixed Amino Acid Infusion Regulates Plasma Insulin-Like Growth Factor-I Concentrations in Fetal Sheep , 1993, Pediatric Research.

[46]  J M Tanner,et al.  Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II. , 1966, Archives of disease in childhood.

[47]  H. Chellani,et al.  Intrauterine growth curves in north Indian babies: weight, length, head circumference and ponderal index. , 1990, Indian pediatrics.

[48]  E. Anggard,et al.  The insulin-like growth factors: their putative role in atherogenesis. , 1991, Artery.

[49]  J. Argente,et al.  Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes. , 1993, The Journal of clinical endocrinology and metabolism.